Integrin beta 2
In molecular biology, CD18 is an integrin beta chain protein that is encoded by the ITGB2 gene in humans. Upon binding with one of a number of alpha chains, CD18 is capable of forming multiple heterodimers, which play significant roles in cellular adhesion and cell surface signaling, as well as important roles in immune responses. CD18 also exists in soluble, ligand binding forms. Genetically-inherited deficiencies in the ITGB2 gene can lead to reduced surface expression of the CD18 protein, leading to the immunodeficiency leukocyte adhesion deficiency.
Structure and function
The ITGB2 protein product is CD18. Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain, and are crucial for cells to be able to efficiently bind to the extracellular matrix. This is especially important for neutrophils, as cellular adhesion plays a large role in extravasation from the blood vessels. A given chain may combine with multiple partners resulting in different integrins.The known binding partners of CD18 are CD11a, CD11b, CD11c and CD11d. Binding of CD18 and CD11a results in the formation of lymphocyte function-associated antigen-1, a protein found on B cells, all T cells, monocytes, neutrophils and NK cells. LFA-1 is involved in adhesion and binding to antigen presenting cells through interactions with the surface protein ICAM-1.
Binding of CD18 and CD11b-d results in the formation of complement receptors, which are proteins found largely on neutrophils, macrophages and NK cells. These complement receptors participate in the innate [immune response] by recognizing foreign antigen peptides and phagocytizing them, thus destroying the antigen.